Premier Diagnostic Health Services Inc.
CNSX : PDH

Premier Diagnostic Health Services Inc.

March 03, 2011 09:30 ET

Premier Diagnostic Health Services Inc. (CNSX:PDH) Announces the Appointment of a Director-International Sales

VANCOUVER, BRITISH COLUMBIA--(Marketwire - March 3, 2011) - Premier Diagnostic Health Services Inc. (CNSX:PDH) ("PDH") is pleased to announce the appointment of Leonhard Braunizer as the Company's Director-International Sales.

Mr. Braunizer brings to the company 19 years of experience in marketing and sales management focused on medical technology in multilingual markets. Since 1997, he has been responsible for the sales management of medical devices of companies in various regions of the world, including, specifically, China and other Asia-Pacific Countries, interfacing with Health Authorities, Government Departments, Emergency Services providers and Specialist Hospitals. 

Mr. Braunizer has developed a strong network of sales representatives in China, and has been authorized by PDH to concentrate his initial efforts on the development and management of PDH's China Development Program.

"We have been acquainted with Leonhard and his international marketing activities for some time, and are very pleased to have attracted this level of expertise to the PDH team," said Denis Tusar, CEO of PDH. "His appointment is very timely for us as we have been developing some initiatives in China that are now maturing."

About Premier Diagnostics Health Services Inc. (CNSX:PDH)

As leaders in advanced health and education with the international medical community, PDH is rolling out its global strategy of establishing a network of Centres for Advanced Diagnostics in Canada and China. By utilizing MRI and PET-CT, the most advanced medical diagnostic imaging technology available and the production of FDG, the radiopharmaceutical tracer used in oncology PET procedures; PDH is uniquely positioned to deliver continued innovation, growth and profitability.

Contact Information